Apple Teams With OpenEvidence on Study of an Experimental AI Health Chat App
Apple

Apple Teams With OpenEvidence on Study of an Experimental AI Health Chat App

Apple and OpenEvidence have started a research study centered on an experimental health chat application powered by artificial intelligence. The partnership was unveiled on Sunday at the HLTH conference in Las Vegas.

The project is framed as a study rather than a product launch, but it offers an early signal of where both companies may be heading as conversational AI moves deeper into consumer health, according to a report by STAT.

What the Study Sets Out to Measure

Sumbul Desai, Apple's vice president of health and fitness, said the effort grew out of the company's emphasis on scientific rigor. The goal is to understand how ordinary people interact with health chatbots that respond in natural language.

Speaking on stage, Desai described several areas of focus: what makes users trust the tool, how well they understand its answers, and the overall quality of those answers. She added that Apple wanted a clinically grounded partner for the work.

Why OpenEvidence Is the Partner

OpenEvidence is known for an AI tool that helps clinicians search and summarize medical literature, which has made it a familiar name among physicians. Its strength with professional users gives Apple a medical anchor for a consumer-facing experiment.

OpenEvidence CEO Daniel Nadler pitched the pairing as complementary, arguing that his company is a favorite among doctors while Apple holds a similar position with consumers, especially those focused on health. He compared the combination to "peanut butter and jelly."

A Possible Shift for Both Companies

For Apple, the study fits a longer pattern of health research tied to its devices and software, including the Health app and Apple Watch. Testing a conversational AI tool for health questions, however, would be a newer area for the company.

For OpenEvidence, the collaboration points toward a potential audience beyond clinicians. Reaching consumers would carry different expectations around clarity, safety and trust than serving trained medical professionals.

Details Still to Come

Much remains unclear from the announcement, including how participants will be enrolled, how long the study will run and whether any findings will lead to a commercial product.

Neither company indicated that the experimental app is a step toward a specific release. The framing as research suggests both are proceeding cautiously in a field where accuracy and user understanding carry real stakes.

What It Means for Health Tech Builders

The study highlights a central question for anyone building consumer health AI: not just whether answers are correct, but whether people trust and understand them. Those factors may matter as much as raw model performance.

For founders in the space, the partnership also shows the value of pairing consumer reach with clinical credibility. How Apple and OpenEvidence handle trust and comprehension could shape expectations for health chatbots across the industry.

Source: STAT

Topics:

JeffkomStory Team

Editorial, JeffKom Story

The JeffKom Story newsroom covers startups, founders, funding and the technology shaping what’s next.

Keep reading

Andreessen Horowitz Makes Its Case That AI Will Turn Pharma Into an Even Bigger Business
Venture

Andreessen Horowitz Makes Its Case That AI Will Turn Pharma Into an Even Bigger Business

More in Apple